Novartis Investigative Site

Barcelona, Catalunya 08035

We've found

1 trials

at this facility

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Barcelona,

Use our guide to learn which trials are right for you!